Form D · Pharmaceuticals
vTv Therapeutics Inc.
High Point, NC · CIK 0001641489
Offering snapshot reported Mar 7, 2024 · SEC filing
- Reported sold
- $51M Offering amount: $51M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 7, 2024 | Initial | $50,961,457 | No comparison | 4 | SEC filing |
| Jan 17, 2020 | Initial | $2,000,000 | No comparison | 0 | SEC filing |
| Oct 15, 2019 | Initial | $2,000,000 | No comparison | 0 | SEC filing |
| Jul 9, 2019 | Initial | $4,000,000 | No comparison | 0 | SEC filing |
| Jan 4, 2019 | Initial | $1,500,000 | No comparison | 0 | SEC filing |
| Aug 10, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 19, 2017 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506977
Source: Form D, filed Mar 7, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Srinivas Akkaraju | Director |
| Fahed Al Marzooqi | Director |
| Larry Altstiel | Executive |
| Raymond Cheong | Director |
| Steven Cohen | Director |
| John A. Fry | Director |
| Keith Harris | Director |
| Stephen Holcombe | Executive |
| Rudy Howard | Executive |
| Jeffrey Kindler | Director |
| Hersh Kozlov | Director |
| Paul Meister | Director |
| Richard Nelson | Director, Executive |
| Craig Parker | Director |
| Paul Savas | Director |
| Paul J. Sekhri | Director, Executive |
| Noel Spiegel | Director |
| Steven Tuch | Executive |
| Howard L. Weiner | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3980 Premier Dr Suite 310
High Point, NC, 27265
High Point, NC, 27265